Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Postdecision Evidence Integration and Depressive Symptoms.

Moses-Payne ME, Rollwage M, Fleming SM, Roiser JP.

Front Psychiatry. 2019 Sep 23;10:639. doi: 10.3389/fpsyt.2019.00639. eCollection 2019.

2.

Optimal use of reminders: Metacognition, effort, and cognitive offloading.

Gilbert SJ, Bird A, Carpenter JM, Fleming SM, Sachdeva C, Tsai PC.

J Exp Psychol Gen. 2019 Aug 26. doi: 10.1037/xge0000652. [Epub ahead of print]

PMID:
31448938
3.

What Underlies Political Polarization? A Manifesto for Computational Political Psychology.

Rollwage M, Zmigrod L, de-Wit L, Dolan RJ, Fleming SM.

Trends Cogn Sci. 2019 Oct;23(10):820-822. doi: 10.1016/j.tics.2019.07.006. Epub 2019 Aug 15.

PMID:
31422899
4.

Metacognition in functional cognitive disorder- a potential mechanism and treatment target.

Bhome R, McWilliams A, Huntley JD, Fleming SM, Howard RJ.

Cogn Neuropsychiatry. 2019 Sep;24(5):311-321. doi: 10.1080/13546805.2019.1651708. Epub 2019 Aug 7.

PMID:
31389291
5.

Erratum: How experimental procedures influence estimates of metacognitive ability.

Rahnev D, Fleming SM.

Neurosci Conscious. 2019 Jul 15;2019(1):niz010. doi: 10.1093/nc/niz010. eCollection 2019.

6.

Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.

Patterson JR, Duffy MF, Kemp CJ, Howe JW, Collier TJ, Stoll AC, Miller KM, Patel P, Levine N, Moore DJ, Luk KC, Fleming SM, Kanaan NM, Paumier KL, El-Agnaf OMA, Sortwell CE.

Neurobiol Dis. 2019 Oct;130:104525. doi: 10.1016/j.nbd.2019.104525. Epub 2019 Jul 2.

7.

A role for metamemory in cognitive offloading.

Hu X, Luo L, Fleming SM.

Cognition. 2019 Jul 1;193:104012. doi: 10.1016/j.cognition.2019.104012. [Epub ahead of print]

8.

How experimental procedures influence estimates of metacognitive ability.

Rahnev D, Fleming SM.

Neurosci Conscious. 2019 Jun 9;2019(1):niz009. doi: 10.1093/nc/niz009. eCollection 2019. Erratum in: Neurosci Conscious. 2019 Jul 15;2019(1):niz010.

9.

Perceptual sensitivity is modulated by what others can see.

Seow T, Fleming SM.

Atten Percept Psychophys. 2019 Aug;81(6):1979-1990. doi: 10.3758/s13414-019-01724-5.

10.

Opportunities and challenges for a maturing science of consciousness.

Michel M, Beck D, Block N, Blumenfeld H, Brown R, Carmel D, Carrasco M, Chirimuuta M, Chun M, Cleeremans A, Dehaene S, Fleming SM, Frith C, Haggard P, He BJ, Heyes C, Goodale MA, Irvine L, Kawato M, Kentridge R, King JR, Knight RT, Kouider S, Lamme V, Lamy D, Lau H, Laureys S, LeDoux J, Lin YT, Liu K, Macknik SL, Martinez-Conde S, Mashour GA, Melloni L, Miracchi L, Mylopoulos M, Naccache L, Owen AM, Passingham RE, Pessoa L, Peters MAK, Rahnev D, Ro T, Rosenthal D, Sasaki Y, Sergent C, Solovey G, Schiff ND, Seth A, Tallon-Baudry C, Tamietto M, Tong F, van Gaal S, Vlassova A, Watanabe T, Weisberg J, Yan K, Yoshida M.

Nat Hum Behav. 2019 Feb;3(2):104-107. doi: 10.1038/s41562-019-0531-8. No abstract available.

11.

Forming global estimates of self-performance from local confidence.

Rouault M, Dayan P, Fleming SM.

Nat Commun. 2019 Mar 8;10(1):1141. doi: 10.1038/s41467-019-09075-3.

12.

Revealing subthreshold motor contributions to perceptual confidence.

Gajdos T, Fleming SM, Saez Garcia M, Weindel G, Davranche K.

Neurosci Conscious. 2019 Feb 18;2019(1):niz001. doi: 10.1093/nc/niz001. eCollection 2019.

13.

Domain-general enhancements of metacognitive ability through adaptive training.

Carpenter J, Sherman MT, Kievit RA, Seth AK, Lau H, Fleming SM.

J Exp Psychol Gen. 2019 Jan;148(1):51-64. doi: 10.1037/xge0000505.

14.

Metacognitive Failure as a Feature of Those Holding Radical Beliefs.

Rollwage M, Dolan RJ, Fleming SM.

Curr Biol. 2018 Dec 17;28(24):4014-4021.e8. doi: 10.1016/j.cub.2018.10.053.

15.

Thinking about thinking: A coordinate-based meta-analysis of neuroimaging studies of metacognitive judgements.

Vaccaro AG, Fleming SM.

Brain Neurosci Adv. 2018 Nov 13;2:2398212818810591. doi: 10.1177/2398212818810591. eCollection 2018. Review.

16.

An Informal Internet Survey on the Current State of Consciousness Science.

Michel M, Fleming SM, Lau H, Lee ALF, Martinez-Conde S, Passingham RE, Peters MAK, Rahnev D, Sergent C, Liu K.

Front Psychol. 2018 Nov 5;9:2134. doi: 10.3389/fpsyg.2018.02134. eCollection 2018.

17.

Human metacognition across domains: insights from individual differences and neuroimaging.

Rouault M, McWilliams A, Allen MG, Fleming SM.

Personal Neurosci. 2018 Aug 10;1. pii: e17. doi: 10.1017/pen.2018.16. Epub 2018 Oct 12.

18.

Shouldering responsibility.

Fleming SM, Bang D.

Science. 2018 Aug 3;361(6401):449-450. doi: 10.1126/science.aau5392. No abstract available.

PMID:
30072525
19.

Distinct encoding of decision confidence in human medial prefrontal cortex.

Bang D, Fleming SM.

Proc Natl Acad Sci U S A. 2018 Jun 5;115(23):6082-6087. doi: 10.1073/pnas.1800795115. Epub 2018 May 21.

20.

Neural mediators of changes of mind about perceptual decisions.

Fleming SM, van der Putten EJ, Daw ND.

Nat Neurosci. 2018 Apr;21(4):617-624. doi: 10.1038/s41593-018-0104-6. Epub 2018 Mar 12.

21.

Domain-General and Domain-Specific Patterns of Activity Supporting Metacognition in Human Prefrontal Cortex.

Morales J, Lau H, Fleming SM.

J Neurosci. 2018 Apr 4;38(14):3534-3546. doi: 10.1523/JNEUROSCI.2360-17.2018. Epub 2018 Mar 8.

22.

Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo-perceptual deficits.

Weil RS, Schwarzkopf DS, Bahrami B, Fleming SM, Jackson BM, Goch TJC, Saygin AP, Miller LE, Pappa K, Pavisic I, Schade RN, Noyce AJ, Crutch SJ, O'Keeffe AG, Schrag AE, Morris HR.

Mov Disord. 2018 Apr;33(4):544-553. doi: 10.1002/mds.27311. Epub 2018 Feb 23.

23.

Psychiatric Symptom Dimensions Are Associated With Dissociable Shifts in Metacognition but Not Task Performance.

Rouault M, Seow T, Gillan CM, Fleming SM.

Biol Psychiatry. 2018 Sep 15;84(6):443-451. doi: 10.1016/j.biopsych.2017.12.017. Epub 2018 Jan 11.

24.

Ahr and Cyp1a2 genotypes both affect susceptibility to motor deficits following gestational and lactational exposure to polychlorinated biphenyls.

Colter BT, Garber HF, Fleming SM, Fowler JP, Harding GD, Hooven MK, Howes AA, Infante SK, Lang AL, MacDougall MC, Stegman M, Taylor KR, Curran CP.

Neurotoxicology. 2018 Mar;65:125-134. doi: 10.1016/j.neuro.2018.01.008.

25.

Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein.

Dirr ER, Ekhator OR, Blackwood R, Holden JG, Masliah E, Schultheis PJ, Fleming SM.

Behav Brain Res. 2018 May 2;343:41-49. doi: 10.1016/j.bbr.2018.01.029. Epub 2018 Feb 3.

26.

Changing Body Movement Patterns in 9-Year-Old Baseball Pitchers: A Pilot Study.

Fehringer EV, Dilisio MF, Greco CE, Fleming SM, Brezenski JW, High RR.

Orthop J Sports Med. 2017 Jun 28;5(6):2325967117713023. doi: 10.1177/2325967117713023. eCollection 2017 Jun.

27.

The effect of manganese exposure in Atp13a2-deficient mice.

Fleming SM, Santiago NA, Mullin EJ, Pamphile S, Karkare S, Lemkuhl A, Ekhator OR, Linn SC, Holden JG, Aga DS, Roth JA, Liou B, Sun Y, Shull GE, Schultheis PJ.

Neurotoxicology. 2018 Jan;64:256-266. doi: 10.1016/j.neuro.2017.06.005. Epub 2017 Jun 6.

PMID:
28595912
28.

HMeta-d: hierarchical Bayesian estimation of metacognitive efficiency from confidence ratings.

Fleming SM.

Neurosci Conscious. 2017 Apr 22;2017(1):nix007. doi: 10.1093/nc/nix007. eCollection 2017.

29.

Mechanisms of Gene-Environment Interactions in Parkinson's Disease.

Fleming SM.

Curr Environ Health Rep. 2017 Jun;4(2):192-199. doi: 10.1007/s40572-017-0143-2. Review.

PMID:
28417442
30.

Suboptimal Criterion Learning in Static and Dynamic Environments.

Norton EH, Fleming SM, Daw ND, Landy MS.

PLoS Comput Biol. 2017 Jan 3;13(1):e1005304. doi: 10.1371/journal.pcbi.1005304. eCollection 2017 Jan.

31.

Self-evaluation of decision-making: A general Bayesian framework for metacognitive computation.

Fleming SM, Daw ND.

Psychol Rev. 2017 Jan;124(1):91-114. doi: 10.1037/rev0000045.

32.

Allostatic Self-efficacy: A Metacognitive Theory of Dyshomeostasis-Induced Fatigue and Depression.

Stephan KE, Manjaly ZM, Mathys CD, Weber LA, Paliwal S, Gard T, Tittgemeyer M, Fleming SM, Haker H, Seth AK, Petzschner FH.

Front Hum Neurosci. 2016 Nov 15;10:550. eCollection 2016.

33.

Changing our minds about changes of mind.

Fleming SM.

Elife. 2016 Mar 7;5:e14790. doi: 10.7554/eLife.14790.

34.

Metacognitive impairment in active cocaine use disorder is associated with individual differences in brain structure.

Moeller SJ, Fleming SM, Gan G, Zilverstand A, Malaker P, d'Oleire Uquillas F, Schneider KE, Preston-Campbell RN, Parvaz MA, Maloney T, Alia-Klein N, Goldstein RZ.

Eur Neuropsychopharmacol. 2016 Apr;26(4):653-62. doi: 10.1016/j.euroneuro.2016.02.009. Epub 2016 Feb 10.

35.

Unexpected but Incidental Positive Outcomes Predict Real-World Gambling.

Otto AR, Fleming SM, Glimcher PW.

Psychol Sci. 2016 Mar;27(3):299-311. doi: 10.1177/0956797615618366. Epub 2016 Jan 21.

PMID:
26796614
36.

Metacognition about the past and future: quantifying common and distinct influences on prospective and retrospective judgments of self-performance.

Fleming SM, Massoni S, Gajdos T, Vergnaud JC.

Neurosci Conscious. 2016 Jan;2016(1):niw018. doi: 10.1093/nc/niw018. Epub 2016 Oct 10.

37.

Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease.

Grant LM, Kelm-Nelson CA, Hilby BL, Blue KV, Paul Rajamanickam ES, Pultorak JD, Fleming SM, Ciucci MR.

J Neurosci Res. 2015 Nov;93(11):1713-27. doi: 10.1002/jnr.23625. Epub 2015 Jul 31.

38.

Relating Pupil Dilation and Metacognitive Confidence during Auditory Decision-Making.

Lempert KM, Chen YL, Fleming SM.

PLoS One. 2015 May 7;10(5):e0126588. doi: 10.1371/journal.pone.0126588. eCollection 2015.

39.

Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein.

Magen I, Ostritsky R, Richter F, Zhu C, Fleming SM, Lemesre V, Stewart AJ, Morimoto BH, Gozes I, Chesselet MF.

Pharmacol Res Perspect. 2014 Oct;2(5):e00065. doi: 10.1002/prp2.65. Epub 2014 Aug 6.

40.

Action-specific disruption of perceptual confidence.

Fleming SM, Maniscalco B, Ko Y, Amendi N, Ro T, Lau H.

Psychol Sci. 2015 Jan;26(1):89-98. doi: 10.1177/0956797614557697. Epub 2014 Nov 25. Erratum in: Psychol Sci. 2015 Apr;26(4):551.

41.

Consciousness science: real progress and lingering misconceptions.

Block N, Carmel D, Fleming SM, Kentridge RW, Koch C, Lamme VA, Lau H, Rosenthal D.

Trends Cogn Sci. 2014 Nov;18(11):556-7. doi: 10.1016/j.tics.2014.09.004. Epub 2014 Oct 4. No abstract available.

PMID:
25287833
42.
43.

Dopamine, Salience, and Response Set Shifting in Prefrontal Cortex.

Shiner T, Symmonds M, Guitart-Masip M, Fleming SM, Friston KJ, Dolan RJ.

Cereb Cortex. 2015 Oct;25(10):3629-39. doi: 10.1093/cercor/bhu210. Epub 2014 Sep 21.

44.

Olfactory assays for mouse models of neurodegenerative disease.

Lehmkuhl AM, Dirr ER, Fleming SM.

J Vis Exp. 2014 Aug 25;(90):e51804. doi: 10.3791/51804.

45.

Domain-specific impairment in metacognitive accuracy following anterior prefrontal lesions.

Fleming SM, Ryu J, Golfinos JG, Blackmon KE.

Brain. 2014 Oct;137(Pt 10):2811-22. doi: 10.1093/brain/awu221. Epub 2014 Aug 6.

46.

How to measure metacognition.

Fleming SM, Lau HC.

Front Hum Neurosci. 2014 Jul 15;8:443. doi: 10.3389/fnhum.2014.00443. eCollection 2014. Review.

47.

Effects of age on metacognitive efficiency.

Palmer EC, David AS, Fleming SM.

Conscious Cogn. 2014 Aug;28:151-60. doi: 10.1016/j.concog.2014.06.007. Epub 2014 Jul 26.

48.

A GCase chaperone improves motor function in a mouse model of synucleinopathy.

Richter F, Fleming SM, Watson M, Lemesre V, Pellegrino L, Ranes B, Zhu C, Mortazavi F, Mulligan CK, Sioshansi PC, Hean S, De La Rosa K, Khanna R, Flanagan J, Lockhart DJ, Wustman BA, Clark SW, Chesselet MF.

Neurotherapeutics. 2014 Oct;11(4):840-56. doi: 10.1007/s13311-014-0294-x.

49.

Ribosomal s15: A novel therapeutic target for Parkinson's disease.

Fleming SM, Espay AJ.

Mov Disord. 2014 Jul;29(8):990. doi: 10.1002/mds.25932. Epub 2014 May 27. No abstract available.

PMID:
24865568
50.

Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.

Richter F, Gao F, Medvedeva V, Lee P, Bove N, Fleming SM, Michaud M, Lemesre V, Patassini S, De La Rosa K, Mulligan CK, Sioshansi PC, Zhu C, Coppola G, Bordet T, Pruss RM, Chesselet MF.

Neurobiol Dis. 2014 Sep;69:263-75. doi: 10.1016/j.nbd.2014.05.012. Epub 2014 May 18.

Supplemental Content

Loading ...
Support Center